Micro-choice-based approach to fatigue management
Official title: Micro-choice-based Intervention for Multicausal Fatigue: Proof of Concept Study
Run by University Hospital, Basel, Switzerland · NCT07726082 · Data updated 2026-11-12
A small study in Basel will test a new four-day group program using micro-choices to help people with fatigue from multiple causes see if it’s doable, acceptable, and may help daily functioning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Status | Recruiting |
| Started | August 13, 2026 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT07726082 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with persistent fatigue significantly impacting daily functioning (Chalder Fatigue Scale bimodal ≥ 4) who can participate in a German-language group program.
✕Probably not a fit
Patients unable to participate in group-format therapy or with conditions that severely limit participation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a proof-of-concept study conducted in Switzerland to explore a multimodal micro-choice-based intervention for persistent fatigue across conditions such as post-viral fatigue and Long COVID. The program includes a preparation phase, a four-day intensive group treatment, and a follow-up to support behavior integration. The study aims to determine feasibility, acceptability, and potential quality-of-life benefits, addressing a gap in care for fatigue syndromes in the region. If feasible, the approach could support return to daily and occupational activities and potentially reduce long-term disability and healthcare costs.
Why it matters
Potential benefit: If successful, participants might experience improved daily functioning and quality of life and better reintegration into work and daily activities.
How similar studies have gone: There is limited prior work on micro-choice-based or multimodal group interventions for fatigue, making this a relatively novel approach in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Experiencing persistent fatigue with a significant impact on daily functioning (Chalder Fatigue- Scale bimodal ≥ 4) Exclusion Criteria: * Have insufficient proficiency in German to complete study-related questionnaires * Lack the cognitive capacity to understand study procedures (e.g. due to dementia) * Present with severe medical conditions that may interfere with participation (e.g., advanced organ failure, uncontrolled inflammatory or autoimmune diseases, or severe psychiatric disorders) * Have active cancer or are currently undergoing cancer treatment * Are deemed incompatible with group participation during the preparation phase, based on a team assessment. Reasons for exclusion based on group incompatibility include: 1. Need for a level of individual therapeutic support that exceeds what can be provided in a group setting; b) Refusal to engage in group-based therapy; c) Personality traits that are considered incompatible with group dynamics; d) Failure to attend the mandatory preparatory webinar (no-show is considered a no-go); e) Other significant reasons as determined by the therapeutic team)
Where it's running
-
University Hospital Basel
Basel, Switzerland Recruiting
Study contacts
- Principal investigator: Katrin Bopp, Dr. — University Hospital, Basel, Switzerland
- Study coordinator: Katrin Bopp, Dr.
- Email: katrin.bopp@usb.ch
- Phone: +41 61 265 50 05
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rehabilitation program to reduce fatigue after COVID-19
This study is testing a new rehabilitation program called COVIDEx to see if it can help people with Long COVID feel less tired compared to standard care.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
HBS-301 for Narcolepsy: daily wakefulness and sleepiness improvement in adults
This Phase 3 study tests HBS-301 vs placebo in adults with narcolepsy to see if it helps with daytime sleepiness, cataplexy, sleepiness, and fatigue.
-
See if Nuvastatic helps with cancer-related fatigue in colon cancer patients on first-line chemotherapy
This trial tests whether Nuvastatic can lessen fatigue in adults with colon cancer who are receiving their first round of chemotherapy, compared to placebo.
-
Balance and gait in multiple sclerosis: linking motion data to function
Researchers will see if precise motion measurements of balance and walking relate to everyday functional tests in adults with MS.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.